CIK 0001368514 · Large accelerated filer
ADMA BIOLOGICS, INC.
Sign in to watch- Ticker
- ADMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 562590442
- Phone
- (201) 478-5552
- Business address
- C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17, RAMSEY, NJ, 07446
- Former names
- R&R ACQUISITION VI, INC
- 4 Open-market buy President & CEO bought 1,875 shares at $9.59 ($17,981)
- 4 Open-market buy President & CEO bought 425 shares at $9.50 ($4,038)
- 4 Open-market buy President & CEO bought 200 shares at $9.00 ($1,800)
- ARS Other Annual Report to Security Holders
- 4 Open-market buy President & CEO bought 500 shares at $8.24 ($4,120)
- 4 Open-market buy Chief Financial Officer bought 500 shares at $8.06 ($4,030)
- 4 Open-market buy President & CEO bought 4,226 shares at an average $8.15 ($34,435)
- 4 Open-market buy President & CEO bought 874 shares at $8.07 ($7,053)
- 4 Open-market buy President & CEO bought 13,400 shares at an average $7.50 ($100,475)
- 4 Open-market buy Chief Financial Officer bought 1,000 shares at $7.50 ($7,500)
- 4 Open-market buy CSO/CMO bought 1,315 shares at $7.60 ($9,994)
- DEFR14A Other DEFR14A
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- DEF 14A Proxy Proxy Statement
- CT ORDER Other Confidential Order
- 8-K Event Results of operations
- 10-K Report Annual Report
- 8-K Event Other events
- 8-K Event Material agreement · New debt or obligation · Executive or director change
Page 42 of 50 · 1,000 filings